3,5-disubstituted pyrid-2-ones useful as inhibitors of Tec family of non-receptor tyrosine kinases

Details for Australian Patent Application No. 2006285038 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Charrier, Jean-Damien; Durrant, Steven; Ramaya, Sham

Agent Cullen & Co

Pub. Number AU-A-2006285038

PCT Pub. Number WO2007/027594

Priority 60/712,642 29.08.05 US

Filing date 29 August 2006

Wipo publication date 8 March 2007

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/027594 Priority application(s): WO2007/027594

24 April 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read FROM: Ramaya, Sham TO: Ramaya, Sharn

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006285040-System, device, and method for conveying information using a rapid serial presentation technique

2006285026-Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators